Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CNS Pharmaceuticals Inc
CNSP
Healthcare
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for...
the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CNSP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 06, 2023 9:46am
CNSP...... Viva CNSP !!!!!
Questa sar una grande vittoria!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 06, 2023 9:40am
CNSP...... Remember ..... the last Financing was done at....
$3.175 Wait for it ; )
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
posted Apr 30, 2024 9:00am by
Mullen Group Ltd.
-
|
"Fortunately, we have a diversified business model that helps mitigate rapid changes in the market and we have the capacity to pursue acquisitions, a core competency and competitive advantage of the Mullen Group. In the current period, for example, acquisitions added approximately $20.5 million in incremental new revenues, and we announced a transaction to acquire ContainerWorld Forwarding Services Inc.." ...read more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 06, 2023 9:36am
CNSP..... This is a complete Joke
Mr. M wants all your paper $5 holla....wait for it
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 06, 2023 9:29am
CNSP...... NR ....I'm late this a.m ; )
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 06, 2023 9:06am
New Press Release - CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Continued advancement of global patient enrollment with approvals and site activations in the U.S., Switzerland, France, Spain and ItalyEnrollment continuing to progress toward an interim analysis expected in the third quarter of 2023HOUSTON, TX / ACCESSWIRE / April 6, 2023 /CNS Pharmaceuticals...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 03, 2023 8:06am
New Press Release - CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Potentially pivotal Phase 2 trial of Berubicinfor the treatment of recurrent glioblastoma multiforme (GBM) demonstrating rapid pace of enrollment globallyCompany on track to report results of the pre-planned interim analysis in the third quarter of 2023HOUSTON, TX / ACCESSWIRE / April 3, 2023...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 29, 2023 9:05am
New Press Release - CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight Event
Live moderated video webcast with members of CNS Pharmacetucals management and Key Opinion Leader, Professor Michael Weller, MD, on Tuesday, April 4th at 3:00 PM ETHOUSTON, March 29, 2023 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 3:37pm
CNSP...... hurry up Dbag....u have 20 mins before close to
make this sub $1 I'm waiting for cheaper...so be my guest...whack away !!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 2:41pm
CNSP...... Sub $1..... Today ?
https://www.youtube.com/watch?v=3uSTOHa4Im4
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 11:16am
CNSP .....Start the drumroll for the sub $1
This will get good & ugly.....all depends what side your on ; ) Stick & Stay to make it Pay..... I always say ! C u at the bottom ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 8:58am
CNSP ..... sub $0.75 fast approaching ; )
It's Official.........Mr. Maggot wants all your paper !!! Welcome everyone to the exciting game of "Spear-catching" !!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 17, 2023 11:36am
RE:CNSP..... Fwiw ; )
Definitely worth a repeat...can't draw any more lines....just catching spears Sheesh
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 15, 2023 12:52pm
CNSP ..... as previously mentioned.....
Even the Maggot isn't supporting this pig ; ) LoL
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 14, 2023 12:44pm
RE:CNSP..... Fwiw ; )
CNSP .......worth a repeat..... $1.20 Come on Mr. M...whack "your " bid ; )
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 13, 2023 7:05am
New Press Release - CNS Pharmaceuticals Announces it Has No Exposure to Silicon Valley Bank Issues
HOUSTON, March 13, 2023 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it is aware...
read article.
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up